Healthy Extracts (HYEX) Revenue Growth (5y) (2020 - 2025)
Healthy Extracts (HYEX) Revenue Growth (5y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Healthy Extracts | 14.70 Mn | 14.56 Mn | 957,429.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 65.63% |
| Sep 30, 2025 | 11.48% |
| Jun 30, 2025 | 44.89% |
| Mar 31, 2025 | 43.75% |
| Dec 31, 2024 | 34.26% |
| Sep 30, 2024 | 22.21% |
| Jun 30, 2024 | 35.21% |
| Mar 31, 2024 | 47.92% |
| Dec 31, 2023 | 266.47% |
| Sep 30, 2023 | 109.50% |
| Jun 30, 2023 | 80.10% |
| Mar 31, 2023 | 98.70% |
| Dec 31, 2022 | 57.51% |
| Sep 30, 2022 | 70.67% |
| Jun 30, 2022 | 65.80% |
| Mar 31, 2022 | 67.37% |
| Dec 31, 2021 | 80.50% |
| Sep 30, 2021 | 84.28% |
| Jun 30, 2021 | 42.68% |
| Mar 31, 2021 | 34.31% |